• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags pharmaceutical division

pharmaceutical division News

Business

Roche Reports a Robust 6% Growth in Q1 Sales, Reaching 15.4 Billion Swiss Francs

Michael Lee 24 Apr, 2025

Roche AG kicks off fiscal 2025 with a 6% increase in Q1 sales to 15.4 billion Swiss francs, driven by an 8% growth in pharmaceuticals. CEO Schinecker outlines plans for a USD 50 bi...

Popular News

  • Business

    Hindustan Zinc Achieves Record-Breaking 47% Profit Surge in Q4, Setting New Benchmarks

    25 Apr, 2025
  • Economy

    Federal Reserve Governor Kugler Affirms US Economy's Strong Foundation Amidst Inflation Concerns

    09 Feb, 2025
  • Market

    European Markets Dip Following ECB Rate Cut and Economic Data Releases

    07 Mar, 2025
  • Business

    Lockheed Martin Launches Astris AI to Revolutionize Defense Industry with AI

    17 Dec, 2024
  • Business

    Oakridge Bengaluru's Innovative Approach to Education Earns Students Early Admission to Elite Global Universities

    25 Mar, 2025
  • Business

    India Unveils Bold Plan to Develop Top 50 Tourist Destinations with State Partnerships

    01 Feb, 2025
  • Business

    Elon Musk Threatens to Withdraw $97.4 Billion OpenAI Offer Over Nonprofit Status

    14 Feb, 2025
  • Business

    Quick Commerce Platforms Under Scrutiny: FMCG Distributors Demand CCI Investigation

    07 Mar, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.